Pay in 4 interest-free payments of $6.50 Learn more
Ships within 48 hours · Estimated delivery Aug 9 - Aug 14
AOD 9604 does not raise blood sugar, does not cause insulin resistance, and does not interfere with tirzepatide insulin-sensitizing effects
Injection Preparation The injection site typically the upper arm or hip is cleansed with an alcohol swab
Increases in resting heart rate are a recognised class effect of incretin-based therapies and have been reported with GLP-1 receptor agonists more broadly, as reflected in the Summary of Product Characteristics (SmPC) for licensed agents such as semaglutide (Wegovy) and liraglutide (Saxenda)
Some individuals may require more frequent injections, while others might benefit from less frequent doses
Being a med school student, my hectic schedule often leaves me fatigued
Baseline and interval laboratory monitoring should include: fasting glucose and HbA1c (tirzepatide can cause hypoglycemia in non-diabetic subjects if caloric intake drops too low), lipase and amylase (pancreatitis risk with GLP-1 agonists), liver function tests (AST, ALT, bilirubin), and thyroid panel (TSH, free T3, free T4)
US$ 29.61
US$ 29.20
US$ 29.02
